MedPath

*Effectiveness of Ultrasound Guided Percutaneous treatment of Lateral Epicondylitis using standardized perforation with application of autologous blood, dextrose or perforation only, in relation to pain and functional recovery; A randomized controlled trial *

Phase 3
Completed
Conditions
lateral epicondylitis
tennis elbow
10043237
Registration Number
NL-OMON47499
Lead Sponsor
Amphia Ziekenhuis
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
165
Inclusion Criteria

• Patients referred by their GP to the orthopaedic surgeon diagnosed with unilateral Lateral Epicondylitis
• Age between 18 and 70 years
• Unsuccessful conservative treatment
• Able to read and write in Dutch
• Provision of informed consent by patient.

Exclusion Criteria

• Prior injection therapy (during this episode of LE), surgery or trauma at the affected elbow
• Inflammatory diseases (i.e. rheumatoid arthritis, psoriatic arthritis, or reactive arthritis)
• Patients with any other elbow pathology
• Neck pain or shoulder pain correlated with elbow pain such as C6 radiculopathy or with disability of the arm or other chronic widespread pain syndromes
• Traumatic onset of LE.
• Bilateral LE (mild cases of LE on the contralateral elbow without functional limitations are allowed).
• Abnormalities on the X-ray.
• Patients with additional pain at the medial epicondyl.
• Allergy for lidocaine

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The main study parameters are the changes in pain using a Visual Analog Scale<br /><br>(VAS, 0-100) (Bodian e.a. 2001) 5 months after treatment:<br /><br>- After provocation test; pain during resisted extension of the wrist during<br /><br>full elbow extension</p><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath